Covista Inc. logo

Covista Inc.(CVSA)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$118.17
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for CVSA

11/13/2026: CVSA (1-star) is currently NOT-A-BUY. Pass it for now.

Covista Inc. is a mid-cap consumer services company operating accredited healthcare, nursing, and professional universities such as Chamberlain and Walden. The company benefits from strong structural demand for nurses and healthcare professionals, driving consistent revenue generation and solid EBITDA margins. Its primary growth strategy centers on expanding hybrid campus footprints and scaling digital professional programs, though it faces ongoing competition and strict regulatory oversight regarding student financial aid. The stock suits value and momentum investors seeking defensive healthcare exposure, with key monitoring items including clinical capacity growth and regulatory compliance.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitSteady single-digit expansion aligns with stable business models rather than hyper-growth tech trajectories.
Momentum investorStrong fit while signal remains positiveRecent positive earnings revisions and upward guidance adjustments create favorable short-term price momentum.
Value investorStrong fitA moderate P/E multiple around 17.5 offers reasonable valuation support relative to consistent cash flows.
Dividend investorWeak fitThe company favors capital reinvestment and share repurchases over significant direct dividend yields.
Low-risk investorMixed fitWhile healthcare demand is defensive, regulatory and accreditation uncertainties introduce headline risks.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumThe stock trades with moderate beta and typical mid-cap price swings around earnings milestones.
Valuation riskLowReasonable earnings multiples limit excessive downside valuation compression.
Competition risk (online & traditional healthcare programs)Medium / highAggressive expansion by traditional universities and online peers tests enrollment growth.
Business qualityStrongHigh franchise quality in specialized healthcare and nursing education provides structural moats.
Dividend incomeLow / noneIncome-focused investors will find minimal direct cash return via dividends.
Execution riskMediumSuccessfully executing campus expansions and maintaining high board pass rates is essential.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.93B USD
Price to earnings Ratio 14.92
1Y Target Price 159
Price to earnings Ratio 14.92
1Y Target Price 159
Volume (30-day avg) 404.1K shares
Beta 0.66
52 Weeks Range 86.97 - 142.13
Updated Date 11/15/2026
52 Weeks Range 86.97 - 142.13
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 7.92

Sector & Industry Intelligence

Sector

Consumer Defensive

Defensive
Sentiment
Correction Expected
Momentum
BUY Breadth Improving
BUY participation
95.0%
Active BUY / eligible
19 / 20
30-Day BUY Count Change
+13
Market state
Correction Expected

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Education & Training Services

BUY participation
50.0%
Active BUY / eligible
1 / 2
30-Day BUY Count Change
-1

Eligible universe: 2 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Rolling Over
PRICE PATH

Rolling Over

The price momentum is slowing down and beginning to turn downward.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 11.34%
Avg. Invested days 61
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
CVSA receives a 4-star rating, supported by solid unit economics, and solid company fundamentals. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
CVSA has solid overall fundamentals (4 stars), with solid financial health, solid growth momentum, and solid ownership. In FY2026 versus FY2025, moderate earnings growth (+8.1%) and strong cash generation (FCF margin 20.1%) are partially offset by moderate revenue growth (+9.3%), modest insider ownership of 2.90%.

Financial Health Rating

★★★★★
CVSA's financial health is supported by solid cash strength, including free-cash-flow generation (20.1% of revenue). Profitability is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is CVSA's strongest growth driver at +36.6% FY2026 versus FY2025 (strong, 5 stars). By comparison, while revenue growth (+9.3%, moderate) and earnings growth (+8.1%, moderate) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 107.9% and approximately 97.3% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 2.90% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 16.48%
FMR Inc 9.68%
Vanguard Portfolio Management, LLC 7.18%
Dimensional Fund Advisors, Inc. 5.58%
Ariel Investments, LLC 5.33%

Unit Economics (Per $1K Revenue)

★★★★★
CVSA generates approximately $573 of gross profit, $196 of operating income, and $201 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Solid margins and strong cash conversion support the rating, although capital efficiency remains solid.

Economic Dimensions

★★★★★
Effective Tax Rate: 22.53%

Quantitative Style Profile

★★★★★
CVSA has a high-quality, liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedQuality TiltLow VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Chamberlain SegmentTuition and fee revenues generated from nursing and allied health degree programs across campuses and online.This is the primary growth engine driven by persistent structural nursing shortages.
Walden SegmentTuition derived from fully online graduate, doctoral, and professional programs.Provides high-margin scalable delivery for working adult professionals.
Medical and Veterinary SegmentTuition and clinical training fees from Caribbean-based medical and veterinary schools.Offers specialized high-value medical training programs supporting long-term professional placement.

Earnings Date

Report Date 2026-10-29
When After Market
Estimate 1.9
Actual 2.19

Profitability

Profit Margin 12.84%
Operating Margin (TTM) 20.07%

Management Effectiveness

Return on Assets (TTM) 8.67%
Return on Equity (TTM) 19.3%

Valuation

Trailing PE 14.92
Forward PE 13.05
Enterprise Value 4.46B
Price to Sales(TTM) 1.96
Enterprise Value 4.46B
Price to Sales(TTM) 1.96
Enterprise Value to Revenue 2.23
Enterprise Value to EBITDA 9.33
Shares Outstanding 33.26M
Shares Floating 32.36M
Shares Outstanding 33.26M
Shares Floating 32.36M
Percent Insiders 2.9
Percent Institutions 107.86

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.